全文获取类型
收费全文 | 3869篇 |
免费 | 189篇 |
国内免费 | 53篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 88篇 |
妇产科学 | 73篇 |
基础医学 | 371篇 |
口腔科学 | 115篇 |
临床医学 | 291篇 |
内科学 | 949篇 |
皮肤病学 | 51篇 |
神经病学 | 440篇 |
特种医学 | 158篇 |
外科学 | 894篇 |
综合类 | 3篇 |
预防医学 | 108篇 |
眼科学 | 105篇 |
药学 | 147篇 |
中国医学 | 2篇 |
肿瘤学 | 271篇 |
出版年
2024年 | 6篇 |
2023年 | 40篇 |
2022年 | 109篇 |
2021年 | 197篇 |
2020年 | 107篇 |
2019年 | 122篇 |
2018年 | 150篇 |
2017年 | 99篇 |
2016年 | 129篇 |
2015年 | 145篇 |
2014年 | 186篇 |
2013年 | 248篇 |
2012年 | 309篇 |
2011年 | 316篇 |
2010年 | 186篇 |
2009年 | 176篇 |
2008年 | 202篇 |
2007年 | 214篇 |
2006年 | 198篇 |
2005年 | 157篇 |
2004年 | 169篇 |
2003年 | 139篇 |
2002年 | 151篇 |
2001年 | 37篇 |
2000年 | 22篇 |
1999年 | 27篇 |
1998年 | 24篇 |
1997年 | 20篇 |
1996年 | 10篇 |
1995年 | 14篇 |
1994年 | 9篇 |
1993年 | 13篇 |
1992年 | 13篇 |
1991年 | 14篇 |
1990年 | 17篇 |
1989年 | 8篇 |
1988年 | 10篇 |
1987年 | 9篇 |
1986年 | 8篇 |
1985年 | 16篇 |
1984年 | 8篇 |
1983年 | 7篇 |
1982年 | 8篇 |
1981年 | 8篇 |
1978年 | 4篇 |
1971年 | 4篇 |
1970年 | 3篇 |
1969年 | 9篇 |
1968年 | 5篇 |
1966年 | 5篇 |
排序方式: 共有4111条查询结果,搜索用时 15 毫秒
101.
Michelangelo Mancuso Daniele Orsucci Corrado Angelini Enrico Bertini Valerio Carelli Giacomo Pietro Comi Maria Alice Donati Antonio Federico Carlo Minetti Maurizio Moggio Tiziana Mongini Filippo Maria Santorelli Serenella Servidei Paola Tonin Antonio Toscano Claudio Bruno Luca Bello Elena Caldarazzo Ienco Elena Cardaioli Michela Catteruccia Paola Da Pozzo Massimiliano Filosto Costanza Lamperti Isabella Moroni Olimpia Musumeci Elena Pegoraro Dario Ronchi Donato Sauchelli Mauro Scarpelli Monica Sciacco Maria Lucia Valentino Liliana Vercelli Massimo Zeviani Gabriele Siciliano 《Journal of neurology》2015,262(5):1301-1309
102.
Francesca D'Arcangelo Alberto Zanetto Camillo Aliberti Sarah Shalaby Monica Pellone Salvatore Stefano Sciarrone Chiara Becchetti Alberto Ferrarese Martina Gambato Francesco Paolo Russo Giacomo Germani Marco Senzolo Alessandro Vitale Umberto Cillo Patrizia Burra 《肝癌研究(英文版)》2021,7(1):38-49
Background: The impact of sarcopenia on the outcome of patients with cirrhosis who undergo liver transplantation (LT) has been analysed in heterogeneous cohorts... 相似文献
103.
Porcaro Antonio Benito Tafuri Alessandro Panunzio Andrea Mazzucato Giovanni Cerrato Clara Gallina Sebastian Bianchi Alberto Rizzetto Riccardo Amigoni Nelia Serafin Emanuele Cianflone Francesco Orlando Rossella Gentile Ilaria Migliorini Filippo Zecchini Antoniolli Stefano Di Filippo Giacomo Brunelli Matteo Pagliarulo Vincenzo Cerruto Maria Angela Antonelli Alessandro 《International urology and nephrology》2022,54(3):541-550
International Urology and Nephrology - To evaluate the influence of endogenous testosterone density (ETD) on pelvic lymph node invasion (PLNI) in high risk (HR) prostate cancer (PCa) treated with... 相似文献
104.
105.
Valeria Righi Nicola Cavallini Antonella Valentini Giampietro Pinna Giacomo Pavesi Maria Cecilia Rossi Annette Puzzolante Adele Mucci Marina Cocchi 《NMR in biomedicine》2020,33(3)
Magnetic resonance imaging (MRI) is the current gold standard for the diagnosis of brain tumors. However, despite the development of MRI techniques, the differential diagnosis of central nervous system (CNS) primary pathologies, such as lymphoma and glioblastoma or tumor‐like brain lesions and glioma, is often challenging. MRI can be supported by in vivo magnetic resonance spectroscopy (MRS) to enhance its diagnostic power and multiproject‐multicenter evaluations of classification of brain tumors have shown that an accuracy around 90% can be achieved for most of the pairwise discrimination problems. However, the survival rate for patients affected by gliomas is still low. The High‐Resolution Magic‐Angle‐Spinning Nuclear Magnetic Resonance (HR‐MAS NMR) metabolomics studies may be helpful for the discrimination of gliomas grades and the development of new strategies for clinical intervention. Here, we propose to use T2‐filtered, diffusion‐filtered and conventional water‐presaturated spectra to try to extract as much information as possible, fusing the data gathered by these different NMR experiments and applying a chemometric approach based on Multivariate Curve Resolution (MCR). Biomarkers important for glioma's discrimination were found. In particular, we focused our attention on cystathionine (Cyst) that shows promise as a biomarker for the better prognosis of glioma tumors. 相似文献
106.
Alessandro Beneduce MD Cristina Capogrosso MD Francesco Moroni MD Francesco Ancona MD Giulio Falasconi MD Luigi Pannone MD Stefano Stella MD Giacomo Ingallina MD Francesco Melillo MD Marco Bruno Ancona MD Vittorio Romano RT Anna Palmisano MD Azeem Latib MD Antonio Colombo MD Matteo Montorfano MD Antonio Esposito MD Eustachio Agricola MD 《Echocardiography (Mount Kisco, N.Y.)》2020,37(12):2071-2081
107.
108.
Yang S Wang X Contino G Liesa M Sahin E Ying H Bause A Li Y Stommel JM Dell'antonio G Mautner J Tonon G Haigis M Shirihai OS Doglioni C Bardeesy N Kimmelman AC 《Genes & development》2011,25(7):717-729
Macroautophagy (autophagy) is a regulated catabolic pathway to degrade cellular organelles and macromolecules. The role of autophagy in cancer is complex and may differ depending on tumor type or context. Here we show that pancreatic cancers have a distinct dependence on autophagy. Pancreatic cancer primary tumors and cell lines show elevated autophagy under basal conditions. Genetic or pharmacologic inhibition of autophagy leads to increased reactive oxygen species, elevated DNA damage, and a metabolic defect leading to decreased mitochondrial oxidative phosphorylation. Together, these ultimately result in significant growth suppression of pancreatic cancer cells in vitro. Most importantly, inhibition of autophagy by genetic means or chloroquine treatment leads to robust tumor regression and prolonged survival in pancreatic cancer xenografts and genetic mouse models. These results suggest that, unlike in other cancers where autophagy inhibition may synergize with chemotherapy or targeted agents by preventing the up-regulation of autophagy as a reactive survival mechanism, autophagy is actually required for tumorigenic growth of pancreatic cancers de novo, and drugs that inactivate this process may have a unique clinical utility in treating pancreatic cancers and other malignancies with a similar dependence on autophagy. As chloroquine and its derivatives are potent inhibitors of autophagy and have been used safely in human patients for decades for a variety of purposes, these results are immediately translatable to the treatment of pancreatic cancer patients, and provide a much needed, novel vantage point of attack. 相似文献
109.
The clinical relevance of anxiety disorders in schizophrenia has been neglected for a long time and has only recently become the subject of a systematic investigation, although its consequences may have a very negative impact on the outcome and considerably worsen the trajectory of the disease. This could be originally related to the hierarchical organization of the Diagnostic and Statistical Manual of Mental Disorders (DSM) and to the lack of assessment instruments. In this article, we will review the most recent literature concerning two of the most impairing anxiety disorders in comorbidity with schizophrenia, such as panic disorder and social anxiety disorder, briefly analyze the role of anxiety in the prodromal phase of psychosis and provide suggestions for the clinical assessment. 相似文献
110.
Michelangelo Mancuso Daniele Orsucci Corrado Angelini Enrico Bertini Michela Catteruccia Elena Pegoraro Valerio Carelli Maria L. Valentino Giacomo P. Comi Carlo Minetti Claudio Bruno Maurizio Moggio Elena Caldarazzo Ienco Tiziana Mongini Liliana Vercelli Guido Primiano Serenella Servidei Paola Tonin Mauro Scarpelli Antonio Toscano Olimpia Musumeci Isabella Moroni Graziella Uziel Filippo M. Santorelli Claudia Nesti Massimiliano Filosto Costanza Lamperti Massimo Zeviani Gabriele Siciliano 《Movement disorders》2014,29(6):722-728
Myoclonus is a possible manifestation of mitochondrial disorders, and its presence is considered, in association with epilepsy and the ragged red fibers, pivotal for the syndromic diagnosis of MERRF (myoclonic epilepsy with ragged red fibers). However, its prevalence in mitochondrial diseases is not known. The aims of this study are the evaluation of the prevalence of myoclonus in a big cohort of mitochondrial patients and the clinical characterization of these subjects. Based on the database of the “Nation‐wide Italian Collaborative Network of Mitochondrial Diseases,” we reviewed the clinical and molecular data of mitochondrial patients with myoclonus among their clinical features. Myoclonus is a rather uncommon clinical feature of mitochondrial diseases (3.6% of 1,086 patients registered in our database). It is not strictly linked to a specific genotype or phenotype, and only 1 of 3 patients with MERRF harbors the 8344A>G mutation (frequently labeled as “the MERRF mutation”). Finally, myoclonus is not inextricably linked to epilepsy in MERRF patients, but more to cerebellar ataxia. In a myoclonic patient, evidences of mitochondrial dysfunction must be investigated, even though myoclonus is not a common sign of mitochondriopathy. Clinical, histological, and biochemical data may predict the finding of a mitochondrial or nuclear DNA mutation. Finally, this study reinforces the notion that myoclonus is not inextricably linked to epilepsy in MERRF patients, and therefore the term “myoclonic epilepsy” seems inadequate and potentially misleading. © 2014 International Parkinson and Movement Disorder Society 相似文献